Related references
Note: Only part of the references are listed.A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort
P. M. Bet et al.
PHARMACOGENOMICS JOURNAL (2016)
Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study
Raymond Noordam et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Rotterdam Study: 2016 objectives and design update
Albert Hofman et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Identifying genetic loci associated with antidepressant drug response with drug-gene interaction models in a population-based study
Raymond Noordam et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke et al.
NATURE (2015)
Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
Sarah G. Helton et al.
PHARMACOGENOMICS (2015)
Genetics and the placebo effect: the placebome
Kathryn T. Hall et al.
TRENDS IN MOLECULAR MEDICINE (2015)
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
J. M. Biernacka et al.
TRANSLATIONAL PSYCHIATRY (2015)
Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium
Joshua C. Bis et al.
PLOS ONE (2015)
Generalized estimating equations for genome-wide association studies using longitudinal phenotype data
Colleen M. Sitlani et al.
STATISTICS IN MEDICINE (2015)
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
Yuan Ji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis
Jian-Yang Lin et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
Karen Hodgson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
Anubha Mahajan et al.
NATURE GENETICS (2014)
Comparison of study designs used to detect and characterize pharmacogenomic interactions in nonexperimental studies: a simulation study
Christy L. Avery et al.
PHARMACOGENETICS AND GENOMICS (2014)
Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population
Anil K. Giri et al.
PHARMACOGENOMICS (2014)
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval
C. L. Avery et al.
PHARMACOGENOMICS JOURNAL (2014)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Iris Postmus et al.
NATURE COMMUNICATIONS (2014)
Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
Rudolf Uher
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
A Genome-Wide Association Study of Depressive Symptoms
Karin Hek et al.
BIOLOGICAL PSYCHIATRY (2013)
Association Between Genetic Variation in the ABCB1 Gene and Switching, Discontinuation, and Dosage of Antidepressant Therapy Results From the Rotterdam Study
Raymond Noordam et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression
Barbara Arias et al.
NEUROPSYCHOBIOLOGY (2013)
Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population
Zhenxing Yang et al.
GENERAL HOSPITAL PSYCHIATRY (2012)
Convergent Animal and Human Evidence Suggests a Role of PPM1A Gene in Response to Antidepressants
Karim Malki et al.
BIOLOGICAL PSYCHIATRY (2011)
Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes
Martina Teichert et al.
PHARMACOGENETICS AND GENOMICS (2011)
Genome-wide association studies of antidepressant outcome: A brief review
Gonzalo Laje et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Holly A. Garriock et al.
BIOLOGICAL PSYCHIATRY (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M. Kato et al.
MOLECULAR PSYCHIATRY (2010)
Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: A mechanistic evaluation
Andrea Lister et al.
AQUATIC TOXICOLOGY (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Marcus Ising et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts
Bruce M. Psaty et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
A genome-wide association study of acenocoumarol maintenance dosage
Martina Teichert et al.
HUMAN MOLECULAR GENETICS (2009)
Selective serotonin reuptake inhibitors pathway
Katrin Sangkuhl et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic predictors of response to antidepressants in the GENDEP project
Rudolf Uher et al.
PHARMACOGENOMICS JOURNAL (2009)
Pharmacogenomics of antidepressant drugs
Sonja Horstmann et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Incidence and Recurrence of Late-Life Depression
Hendrika J. Luijendijk et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants
Monique J. Bijl et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Practical aspects of imputation-driven meta-analysis of genome-wide association studies
Paul I. W. de Bakker et al.
HUMAN MOLECULAR GENETICS (2008)
Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
Eric J. Peters et al.
PLOS ONE (2008)
Meta-analyses of genetic studies on major depressive disorder
S. Lopez-Leon et al.
MOLECULAR PSYCHIATRY (2008)
Descriptive epidemiology of major depression in Canada
SB Patten et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Epidemiology of major depressive disorder - Results from the National Epidemiologic Survey on Alcoholism and Related Conditions
DS Hasin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Investigation of serotonin-related genes in antidepressant response
EJ Peters et al.
MOLECULAR PSYCHIATRY (2004)
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
LK Durham et al.
PSYCHOPHARMACOLOGY (2004)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Placebo response and antidepressant clinical trial outcome
A Khan et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2003)
Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania
V De Luca et al.
PHARMACOGENOMICS JOURNAL (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Share Paper
